CD44 Facilitates Epithelial to Mesenchymal Transition Phenotypic Change at Acquisition of Resistance to EGFR Kinase Inhibitors in Lung Cancer

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-17-1279

Related search